Sign In
Free Newsletter
Baltimore sues Eli Lilly, other drug giants over cost of insulin
The City of Baltimore is suing Eli Lilly and a group of other drug companies, accusing the drugmakers of conspiring to artificially hike the price of insulin.
Furloughs could become law firm layoffs, report says
Welcome to Monday, the 37th anniversary of the U.S. Supreme Court’s Arizona Governing Committee v. Norris decision that Title VII of the 1964 Civil Rights Act prohibits states from discriminating […]
Startup emocha to make push into chronic disease next year
Following the announcement of a trial partnership to help diabetes patients, Baltimore telemedicine startup emocha Mobile Health plans to expand its scope into chronic disease. With a three-month trial with […]
Maryland doctors to increase diabetes training
The Maryland chapter of the American Diabetes Association will hold its first training for primary care providers, updating them on the latest association standards for the treatment of diabetes. While […]
Md. biopharm to work with another firm on diabetes drug
Germantown-based Intrexon Corp., a synthetic biology firm, now has a research collaboration agreement with another company to work on treatments for diabetes and other health problems. Intrexon will work with […]
WellDoc promotes diabetes management app
BlueStar, which helps users monitor their glucose levels and keep track of medications in real-time, is perhaps the biggest accomplishment to date for WellDoc.
Diabetes group, GBC launch initiative
The Maryland chapter of the American Diabetes Association announced that it is partnering with the Greater Baltimore Committee on an initiative to engage top regional CEOs in the fight against diabetes in the workplace.
Sugar manufacturer joins fight against diabetes
Domino Sugar has partnered with the American Diabetes Association, and workers have raised thousands for diabetes walk.
Jury selection set to begin in wrongful death lawsuit against drug maker
Jury selection is scheduled to begin Tuesday in a Baltimore family’s $10 million wrongful death lawsuit against the maker of the prescription diabetes medication Actos.
FDA OKs first-of-a-kind diabetes drug from J&J
WASHINGTON — The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar. The agency […]
GlaxoSmithKline wins takeover bid for Human Genome
U.K. drug maker GlaxoSmithKline has secured its takeover of longtime partner Human Genome Sciences after agreeing to pay more, a move to expand GSK’s drug portfolio in crucial areas: biologic […]
Human Genome rejects GlaxoSmithKline’s $2.59B bid
The decision by Rockville-based biotech drugmaker Human Genome Sciences Inc. to reject an unsolicited $2.59 billion takeover bid Thursday may increase the eventual sale price of the company, analysts said. […]
